Inventor

Upul K. Bandarage

Inventor
Lexington, MA, US

Overview

37→
Patents
2001–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 37 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes21%
C07CAcyclic or carbocyclic compounds8%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
Y02ATechnologies for adaptation to climate change3%
PatentTitleYear
10,875,855Inhibitors of influenza viruses replication202010,874,673Inhibitors of influenza viruses replication202010,183,933Isoindolinone inhibitors of phosphatidylinositol 3-kinase201910,039,762Inhibitors of influenza viruses replication20189,908,878'Inhibitors of influenza viruses replication'20189,808,459'Inhibitors of influenza viruses replication'20179,676,759'Isoindolinone inhibitors of phosphatidylinositol 3-kinase'20179,518,056'Inhibitors of influenza viruses replication'20169,394,302'Inhibitors of influenza viruses replication'20169,345,708'Inhibitors of influenza viruses replication'20169,051,319'Inhibitors of influenza viruses replication'20158,871,774'Inhibitors of influenza viruses replication'20148,829,007'Inhibitors of influenza viruses replication'20148,546,414'Ion channel modulators and methods of use'20138,524,906'Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase'20138,492,365'7-substituted tetracycline compounds'20138,481,513'3, 10, and 12a substituted tetracycline compounds'20138,466,288'Isoindolinone inhibitors of phosphatidylinositol 3-kinase'20138,344,153'Inhibitors of phosphatidylinositol 3-kinase'20138,278,306'C-met protein kinase inhibitors'20128,236,815'Ion channel modulators and methods of uses'20128,058,271'Selective inhibitors of rock protein kinase and uses thereof'20117,919,520'Inhibitors of tace'20117,863,449'Modulators of muscarinic receptors'20117,858,790'Modulators of muscarinic receptors'20107,825,105'3, 10, and 12a substituted tetracycline compounds'20107,767,680'Ion channel modulators and methods of use'20107,595,309'7-substituted tetracycline compounds'20097,514,448'Azaindoles useful as inhibitors of rock and other protein kinases'20097,485,664'Inhibitors of TACE'20097,442,802'Cyclooxygenase-2 selective inhibitors, compositions and methods of use'20087,432,285'Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use'20087,314,885'Pyrrole compounds useful as kinase inhibitors'20087,087,630'Cyclooxygenase 2 selective inhibitors, compositions and methods of use'20066,649,629'Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use'20036,593,347'Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use'20036,297,260'Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use'2001

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2001–2008Patents assigned to NITROMED INC (6)· patent assignee history
2001–2013Based in Newton, MA, US· patent location history
2006–2020Based in Lexington, MA, US· patent location history
2008–2020Patents assigned to VERTEX PHARMA (27)· patent assignee history
2011–2013Patents assigned to BANDARAGE UPUL (4)· patent assignee history
2011–2013Patents assigned to CAO JINGRONG (4)· patent assignee history
2012–2013Patents assigned to BANDARAGE UPUL KEERTHI (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
VERTEX PHARMA272008–2020
NITROMED INC62001–2008
BANDARAGE UPULself42011–2013
BANDARAGE UPUL KEERTHIself42012–2013
CAO JINGRONG42011–2013
Locations
LocationPatentsSpan
Lexington, Massachusetts, US332006–2020
Newton, Massachusetts, US42001–2013